GNGBF Stock Chart & Stats
$23.48
$0.99(4.40%)
―
--
Day’s Range― - ―
52-Week Range$18.26 - $25.56
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
$6.45B
Enterprise Value$63.06K
Total Cash (Recent Filing)$2.05B
Total Debt (Recent Filing)$11.10B
Price to Earnings (P/E)23.4
Beta0.44
Next Earnings
Oct 20, 2026EPS Estimate
0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)9.83
Shares Outstanding254,152,370
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.70
Price to Book (P/B)2.03
Price to Sales (P/S)1.70
P/FCF Ratio22.62
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$26.75Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)1.21
Revenue Forecast (FY)$3.60B
Bulls Say, Bears Say
Bulls Say
Strong Free Cash FlowSustained high FCF (3.8B TTM) and ~72% conversion indicate the business consistently converts earnings into cash. This supports durable uses—service network investment, product R&D, maintenance of installed base, dividends or deleveraging—improving long-term financial flexibility.
Rebounding ProfitabilityMargins have recovered materially versus the prior troughs, signaling operational recovery from earlier headwinds. Higher EBIT and net margins point to improving pricing, cost control or product mix, which if sustained will raise cash generation and return on invested capital over the medium term.
Installed Base & Recurring RevenueA large installed base that drives services, consumables and maintenance provides predictable, higher-margin recurring revenue. This structural mix dampens cyclicality of capital equipment sales, supports margins and customer stickiness, and underpins steady cash flows over multiple quarters.
Bears Say
Margins Below Pre‑pandemic PeaksDespite recent improvement, current margins remain meaningfully below 2021–2022 peaks. This suggests persistent structural pressures—mix shifts, pricing limits or cost inflation—that could cap profitability and returns until underlying structural issues are addressed.
Rising Leverage Vs Earlier YearsDebt-to-equity rising to 0.35 reduces balance-sheet optionality compared with prior years. Higher leverage can constrain capital allocation, limit ability to absorb shocks, and increase interest sensitivity—weakening flexibility for M&A, large capex or accelerated shareholder returns.
Inconsistent Historical Cash FlowHistoric volatility in free cash flow (declines then recovery) adds uncertainty to planning and capital allocation. Inconsistent cash conversion makes forecasting investments, dividends or deleveraging less reliable and raises execution risk if revenue or margin drivers falter.
Getinge News
GNGBF FAQ
What was Getinge’s price range in the past 12 months?
Getinge lowest stock price was $18.26 and its highest was $25.56 in the past 12 months.
What is Getinge’s market cap?
Getinge’s market cap is $6.45B.
When is Getinge’s upcoming earnings report date?
Getinge’s upcoming earnings report date is Oct 20, 2026 which is in 86 days.
How were Getinge’s earnings last quarter?
Getinge released its earnings results on Jul 17, 2026. The company reported $0.372 earnings per share for the quarter, beating the consensus estimate of $0.225 by $0.147.
Is Getinge overvalued?
According to Wall Street analysts Getinge’s price is currently Undervalued.
Does Getinge pay dividends?
Getinge pays a N/A dividend of $0.515 which represents an annual dividend yield of N/A. See more information on Getinge dividends here
What is Getinge’s EPS estimate?
Getinge’s EPS estimate is 0.26.
How many shares outstanding does Getinge have?
Getinge has 254,152,370 shares outstanding.
What happened to Getinge’s price movement after its last earnings report?
Getinge reported an EPS of $0.372 in its last earnings report, beating expectations of $0.225. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Getinge?
Currently, no hedge funds are holding shares in GNGBF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Getinge
Getinge AB, founded in 1904 and headquartered in Gothenburg, Sweden, is a prominent global supplier of medical technology solutions. The company's extensive portfolio is designed for critical healthcare environments, including operating rooms, intensive care units, and sterile processing facilities. Its operations are divided into three core segments: Acute Care Therapies, Life Science, and Surgical Workflows. Getinge offers a comprehensive array of specialized equipment and systems. This encompasses advanced solutions for sterile processing and containment, such as sterilizers, washers, isolators, and automated logistic systems. For the life sciences sector, they provide bioreactors, bioprocess control systems, and associated analytics tools. Within acute care and surgical settings, their offerings range from anesthesia machines, specialized monitoring systems, and various disposables, to instruments for cardiac surgery (like beating heart stabilizers), mechanical ventilation products, and extracorporeal life support (ECMO) solutions. Additionally, Getinge provides infrastructure for operating rooms, including lighting, tables, modular systems, and integrated management tools, alongside products for cleaning, disinfection, packaging, and comprehensive sterile supply management. Their product line further extends to diverse catheters (thoracic, endovascular), endoscopic vessel harvesting systems, patient flow and transport solutions, and specialized devices for vascular and cardiothoracic surgery. The company distributes its broad range of products globally through its proprietary sales companies, as well as via agents and distributors, serving markets across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region.
GNGBF Stock 12 Month Forecast
Average Price Target
$26.75
Ownership Overview
―
Insiders
3.64% Mutual Funds
0.32% Other Institutional Investors
90.31% Public Companies and
Individual Investors